Technical Analysis for PLI - ProMetic Life Sciences Inc.

Grade Last Price % Change Price Change
grade C 14.4 5.26% 0.720
PLI closed down 12.08 percent on Monday, September 16, 2019, on 78 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical PLI trend table...

Date Alert Name Type % Chg
Evening Star Bearish 5.26%
Fell Below 50 DMA Bearish 5.26%
Stochastic Sell Signal Bearish 5.26%
Upper Bollinger Band Walk Strength 5.26%
Wide Bands Range Expansion 5.26%
Overbought Stochastic Strength 5.26%
Upper Bollinger Band Touch Strength 5.26%
Gapped Down Weakness 5.26%
Shooting Star Candlestick Bearish -7.46%
Lizard Bearish Bearish Day Trade Setup -7.46%

Older signals for PLI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Prometic Life Sciences Inc (ProMetic) is a Canada-based biopharmaceutical company. The Company has two segments: Small Molecule Therapeutics and Protein Technology. The Company offers its technology platform for large-scale drug purification of biologics, drug development, proteomics and the elimination of pathogens to various industries, and uses its own affinity technology that provides for extraction and purification of therapeutic proteins from human plasma in order to develop therapeutics and orphan drugs. ProMetic is also developing its own small molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation and cancer. It has research and development facilities in the United Kingdom, the United States and Canada; manufacturing facilities in the Isle of Man and Canada, and business development activities in the United States, Europe and Asia.
Articles Natural Sciences Biotechnology Cancer Biopharmaceutical Pharmaceutical Industry Drug Development Life Sciences Medication
Is PLI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 22.0
52 Week Low 0.015
Average Volume 20,675
200-Day Moving Average 3.8002
50-Day Moving Average 14.553
20-Day Moving Average 12.5015
10-Day Moving Average 12.997
Average True Range 1.1652
ADX 17.82
+DI 42.5978
-DI 33.0918
Chandelier Exit (Long, 3 ATRs ) 13.5044
Chandelier Exit (Short, 3 ATRs ) 10.6256
Upper Bollinger Band 14.8111
Lower Bollinger Band 10.1919
Percent B (%b) 0.76
BandWidth 36.949166
MACD Line 0.422
MACD Signal Line 0.0977
MACD Histogram 0.3243
Fundamentals Value
Market Cap 9.64 Billion
Num Shares 705 Million
EPS -0.19
Price-to-Earnings (P/E) Ratio -72.00
Price-to-Sales 67.87
Price-to-Book 9.94
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.915
Resistance 3 (R3) 16.103 15.547 15.543
Resistance 2 (R2) 15.547 14.977 15.453 15.418
Resistance 1 (R1) 14.613 14.626 14.335 14.425 15.294
Pivot Point 14.057 14.057 13.918 13.963 14.057
Support 1 (S1) 13.123 13.487 12.845 12.935 12.066
Support 2 (S2) 12.567 13.136 12.473 11.942
Support 3 (S3) 11.633 12.567 11.818
Support 4 (S4) 11.445